These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7956713)

  • 1. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
    Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
    Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
    Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
    Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.
    Grant M; Russell B; Fitzgerald C; Merimee TJ
    Diabetes; 1986 Apr; 35(4):416-20. PubMed ID: 2420665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous levels of insulin-like growth factor-I in patients with proliferative diabetic retinopathy.
    Inokuchi N; Ikeda T; Imamura Y; Sotozono C; Kinoshita S; Uchihori Y; Nakamura K
    Curr Eye Res; 2001 Nov; 23(5):368-71. PubMed ID: 11910526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
    Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity.
    Simó R; Lecube A; García-Arumí J; Carrasco E; Hernández C
    Diabetes Care; 2004 Jan; 27(1):287-8. PubMed ID: 14694016
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.
    Simó R; Lecube A; Sararols L; García-Arumí J; Segura RM; Casamitjana R; Hernández C
    Diabetes Care; 2002 Dec; 25(12):2282-6. PubMed ID: 12453974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor-I in diabetic retinopathy.
    Payne JF; Tangpricha V; Cleveland J; Lynn MJ; Ray R; Srivastava SK
    Mol Vis; 2011; 17():2318-24. PubMed ID: 21921983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
    Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
    Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum and vitreous concentrations of osteoprotegerin with diabetic retinopathy.
    Yu G; Ji X; Jin J; Bu S
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):232-6. PubMed ID: 24723620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
    Boulton M; Gregor Z; McLeod D; Charteris D; Jarvis-Evans J; Moriarty P; Khaliq A; Foreman D; Allamby D; Bardsley B
    Br J Ophthalmol; 1997 Mar; 81(3):228-33. PubMed ID: 9135388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of serum and vitreous adropin concentrations with diabetic retinopathy.
    Li S; Sun J; Hu W; Liu Y; Lin D; Duan H; Liu F
    Ann Clin Biochem; 2019 Mar; 56(2):253-258. PubMed ID: 30514096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.